Legend Biotech (LEGN) EBITDA Margin Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) EBITDA Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | 3,609.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,609.00 |
| Sep 30, 2025 | 2,796.00 |
| Jun 30, 2025 | -3,840.00 |
| Mar 31, 2025 | 1,602.00 |
| Dec 31, 2024 | -4,234.00 |
| Sep 30, 2024 | -619.00 |
| Jun 30, 2024 | 26,565.00 |
| Mar 31, 2024 | 22,465.00 |
| Dec 31, 2023 | 50,857.00 |
| Sep 30, 2023 | 30,373.00 |
| Jun 30, 2023 | 130,343.00 |
| Mar 31, 2023 | -22,780.00 |
| Dec 31, 2022 | -28,068.00 |
| Sep 30, 2022 | 39,873.00 |
| Jun 30, 2022 | -72,920.00 |
| Mar 31, 2022 | -6,587.00 |
| Dec 31, 2021 | -8,636.00 |
| Sep 30, 2021 | -16,861.00 |
| Jun 30, 2021 | 31,103.00 |
| Mar 31, 2021 | 44,934.00 |